Singapore markets closed

Bellevue Life Sciences Acquisition Corp. (BLAC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
10.82+0.10 (+0.93%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 60.84M
Enterprise value 60.98M
Trailing P/E 216.40
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.87
Enterprise value/revenue N/A
Enterprise value/EBITDA -33.31

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 36.60%
S&P500 52-week change 325.59%
52-week high 311.44
52-week low 310.15
50-day moving average 310.68
200-day moving average 310.51

Share statistics

Avg vol (3-month) 330.44k
Avg vol (10-day) 350.25k
Shares outstanding 55.62M
Implied shares outstanding 65.62M
Float 83.12M
% held by insiders 137.36%
% held by institutions 161.15%
Shares short (15 Apr 2024) 42.23k
Short ratio (15 Apr 2024) 40.07
Short % of float (15 Apr 2024) 40.05%
Short % of shares outstanding (15 Apr 2024) 40.04%
Shares short (prior month 15 Mar 2024) 41.41k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-6.05%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)403.78k
Diluted EPS (ttm)0.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.42k
Total cash per share (mrq)0
Total debt (mrq)72k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.01
Book value per share (mrq)-0.69

Cash flow statement

Operating cash flow (ttm)-818.77k
Levered free cash flow (ttm)768.51k